Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
Sheena G Sullivan, Monique B Chilver, Kylie S Carville, Yi-Mo Deng, Kristina A Grant, Geoff Higgins, Naomi Komadina, Vivian KY Leung, Cara A Minney-Smith, Don Teng, Thomas Tran, Nigel Stocks, James E Fielding
Eurosurveillance | EUR CENTRE DIS PREVENTION & CONTROL | Published : 2017
Awarded by National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, USA
We thank the general practitioners, nurse practitioners, and practice staff that participated and contributed to ASPREN and VicSPIN in 2017. We also thank laboratory staff members from the following laboratories who undertook influenza testing and virus characterisation: SA Pathology, Adelaide, South Australia; PathWest Laboratory Medicine, Perth, Western Australia; the Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria; and the WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria. ASPREN and the WHO Collaborating Centre for Reference and Research on Influenza are supported by the Australian Government Department of Health (the Department). The opinions expressed in this paper are those of the authors, and do not necessarily represent the views of the Department. VicSPIN is funded by the Victorian Government Department of Health and Human Services. DT is supported by contract HHSN272201400006C from the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, USA.